News tagged with vandetanib

Vandetanib in thyroid cancer: No proof of added benefit

Vandetanib (trade name Caprelsa) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health ...

Cancer Nov 09, 2012 | not rated yet | 0

Vandetanib doesn't up survival in non-small-cell lung cancer

(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 ...

Cancer Mar 02, 2012 | not rated yet | 0